| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695678 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
As a liquid molecular biopsy, analysis of circulating PIK3CA mutations shows promise as a way to refine risk stratification of individual patients with cervical cancer, and provides a platform for further research to offer individualized therapy with the purpose of improving outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Tony K.H. Chung, Tak Hong Cheung, So Fan Yim, Mei Yun Yu, Rossa W.K. Chiu, Keith W.K. Lo, Ida P.C. Lee, Raymond R.Y. Wong, Kitty K.M. Lau, Vivian W. Wang, Michael J. Jr, Kevin M. Elias, Stephen J. Fiascone, David I. Smith, Ross S. Berkowitz,